The Center for Compassionate Innovation is Extending Hope and Help to Veterans
At the Center for Compassionate Innovation (CCI), we are exploring emerging therapies that may offer hope and help to Veterans.
VA established CCI to be an entry point for safe and ethical innovations that may be successful in treating a subset of Veterans diagnosed with certain health conditions that have not responded to evidence-based therapies. CCI focuses on the conditions below and others that may be resistant to standard treatments:
VA is committed to offering Veterans patient-centric and personalized health care. CCI helps achieve this goal by reviewing and supporting innovative ideas from within and outside VA that have the potential to transform Veterans’ care. CCI looks for new treatments, or novel approaches to existing therapies, that may improve Veterans’ health and well-being and, if effective, be adopted by VA.
CCI invites proposals of emerging therapies through its portal. CCI does not accept research submissions or award commercial contracts for care, research grants or other forms of external financial support.
CCI seeks novel solutions that improve Veterans’ physical and mental well-being. Do you think you have a viable submission? See if your proposal fits the CCI criteria:
It’s safe. Proposals should demonstrate that interventions are safe and ethical to provide to Veterans. The Veterans Health Administration (VHA) will only assess proposals that rigorously maintain the fundamental principle to “do no harm.” Proposals that are unsafe or in conflict with VHA’s mission, vision or goals are declined.
It’s a clinical innovation. Proposed interventions should fall into one of two categories:
- A new idea that has not yet been fully evaluated
- An innovative application of existing modalities for different purposes, health conditions or Veteran populations
It has a clinical benefit. Proposed idea should enhance Veterans’ well-being.
It can be adopted at VA. Proposed idea can be used within VHA.